Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 
 
Innovative Health Care Portfolio, 2  Ticker: FXBDMX
 
 Trust Performance  (as of 7/2/2020) *Inception Date is 11/13/2019 
  Cumulative Total Return Average Annual Total Return
  YTD Since
Inception*
3 mo 6 mo 1 yr 3 yr 5 yr Since
Inception*
Distributions Reinvested
With Transactional
Sales Charge
12.61%  27.89%  32.35%  12.99%  N/A  N/A  N/A  N/A 
Without Transactional
Sales Charge
14.22%  29.64%  34.17%  14.60%  N/A  N/A  N/A  N/A 
Distributions Received in Cash
With Transactional
Sales Charge
12.07%  27.28%  32.35%  12.45%  N/A  N/A  N/A  N/A 
Without Transactional
Sales Charge
13.67%  29.02%  34.17%  14.06%  N/A  N/A  N/A  N/A 
 
HEALTH CARE SEL SECTOR IDX (IXV) 0.63%  8.67%  16.57%  0.41%  N/A  N/A  N/A  N/A 
S&P 500 HEALTH CARE (S5HLTH) 0.63%  8.67%  16.57%  0.42%  N/A  N/A  N/A  N/A 


 Performance Calculator
 From Date: 
To Date: 
  Cumulative
Total Return
Average Annual
Total Return
With Transactional Sales Charge (Distributions Reinvested) 27.89%    N/A   
Without Transactional Sales Charge (Distributions Reinvested) 29.64%    N/A   
With Transactional Sales Charge (Distributions Received in Cash) 27.28%    N/A   
Without Transactional Sales Charge (Distributions Received in Cash) 29.02%    N/A   
S&P 500 HEALTH CARE (S5HLTH) 8.67%    N/A   
HEALTH CARE SEL SECTOR IDX (IXV) 8.67%    N/A   


Sales Charges (based on a $10 public offering price)
Standard Accounts
Transactional Sales Charges: Initial: 0.00%
  Deferred: 1.35%
Creation & Development Fee:   0.50%
Maximum Sales Charge:   1.85%
 
Fee/Wrap Accounts
Creation & Development Fee: 0.50%
Maximum Sales Charge: 0.50%
The table above shows the initial offering period sales charge. Certain performance periods shown on this page may begin after the end of the initial offering period and reflect a secondary market sales charge. Please see the prospectus for sales charge details, including the secondary market sales charge amount applicable to a period.

Past Performance is no indication of future results. Investment returns and principal value will fluctuate and units when sold or redeemed, may be worth more or less than their original cost. All returns are historical and do not represent potential future performance. This report is not and should not be construed as an offer to buy or sell securities.

All index returns assume that dividends are reinvested when they are received.

Returns With Transactional Sales Charge reflect the maximum transactional sales charge that would be payable by an investor upon sale or redemption of units at the end of the applicable period(s). The transactional sales charge includes any initial or deferred sales charges other than the creation and development fee. These returns do not reflect any creation and development fee prior to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.

Returns Without Transactional Sales Charge do not reflect any transactional sales charge and do not reflect any creation and development fee prior to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.

Returns with distributions reinvested assumes distributions are reinvested on the reinvestment date.

Risk Considerations

Closed-End Fund and ETF Risk. Closed-end funds and ETFs are subject to various risks, including management's ability to meet the fund's investment objective, and to manage the fund's portfolio when the underlying securities are redeemed or sold, during periods of market turmoil and as investors' perceptions regarding ETFs, closed-end funds or their underlying investments change. Unlike open-end funds, which trade at prices based on a current determination of the fund's net asset value, ETFs and closed-end funds frequently trade at a discount from their net asset value in the secondary market. Certain closed-end funds in which the portfolio invests may employ the use of leverage, which increases the volatility of such funds.

Closed-End Fund Risk. Closed-end funds are subject to various risks, including management's ability to meet the fund's investment objective, and to manage the fund's portfolio when the underlying securities are redeemed or sold, during periods of market turmoil and as investors' perceptions regarding the funds or their underlying investments change. Unlike open-end funds, which trade at prices based on a current determination of the fund's net asset value, closed-end funds frequently trade at a discount to their net asset value in the secondary market. Certain closed-end funds employ the use of leverage, which increases the volatility of such funds.

COVID-19 Economic Impact Risk. The recent outbreak of a respiratory disease designated as COVID-19 was first detected in China in December 2019. The global economic impact of the COVID-19 outbreak is impossible to predict but is expected to disrupt manufacturing, supply chains and sales in affected areas and negatively impact global economic growth prospects. The COVID-19 outbreak has also caused significant volatility and declines in global financial markets, which have caused losses for investors. The impact of the COVID-19 outbreak may be short term or may last for an extended period of time, and in either case could result in a substantial economic downturn or recession.

Health Care Risk. The companies engaged in the health care sector are subject to fierce competition, high research and development costs, governmental regulations, loss of patent protection, and changing consumer spending trends.

Additional Risk. For a discussion of additional risks of investing in the trust see the "Risk Factors" section of the prospectus.

Important Note. It is important to note that an investment can be made in the underlying funds directly rather than through the trust. These direct investments can be made without paying the trust's sales charge, operating expenses and organizational costs.

Operational Risk. As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.

You should carefully consider the trust's investment objectives, risks, and charges and expenses before investing. Contact your financial professional or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the trust. Read it carefully before you invest.

This product information does not constitute an offer to sell, or a solicitation of an offer to buy securities in any state to any person to whom it is not lawful to make such an offer. Sales of any of these securities must include prospectus delivery and the services of a retail broker/dealer duly licensed in the appropriate states.

Not FDIC Insured, Not Bank Guaranteed and May Lose Value.

Fund Cusip Information
30312A420 (Cash)
30312A438 (Reinvest)
30312A446 (Cash-Fee)
30312A453 (Reinvest-Fee)
Printer Friendly Page Printer Friendly Page
 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2020 All rights reserved.